+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pen Needles Market Size, Share & Trends Analysis Report By Product (Standard & Safety Pen Needles), By Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin, Glucagon-like-Peptide-1), Region And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 105 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 4209732
The global pen needles market size is expected to reach a value of USD 7.7 billion by 2030, expanding at a CAGR of 11.8%, according to this report. Rising prevalence of diabetes is the primary reason for the significant growth of the pen needles market. According to the National Library of Medicine, the number of people with diabetes is expected to climb by 1.51 million in 2023, owing primarily to the ageing population. Such high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology, which will enable diabetic patients with easy adherence to insulin therapy regimens.

Pen Needles Market Report Highlights

  • Standard needles dominated the market in 2022 due to the availability of cost-effective needles as compared to safety needles
  • Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements
  • Amongst the needle lengths, 8mm held the largest share in 2022. This is due to the convenience offered by this needle type on diabetic patients
  • Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length
  • Insulin therapy accounted for the largest market share in 2022 due to rising awareness regarding self-administration of insulin amongst the diabetic patients
  • Europe dominated the pen needles market in 2022 followed by North America owing to the high prevalence of diabetes in the European region
  • Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery
  • Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Pen Needles Market

What is the estimated value of the Global Pen Needles Market?

The Global Pen Needles Market was estimated to be valued at $3.1 Billion in 2022.

What is the growth rate of the Global Pen Needles Market?

The growth rate of the Global Pen Needles Market is 11.8%, with an estimated value of $7.7 Billion by 2030.

What is the forecasted size of the Global Pen Needles Market?

The Global Pen Needles Market is estimated to be worth $7.7 Billion by 2030.

Who are the key companies in the Global Pen Needles Market?

Key companies in the Global Pen Needles Market include Novo Nordisk A/S, Becton, Dickinson and Company, TERUMO CORPORATION, Owen Mumford Ltd., Ypsomed, B. Braun Melsungen AG, HTL, STREFA and UltiMed, Inc..

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Needle Length
1.1.3. Therapy
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Snapshot
Chapter 3. Pen Needles Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing prevalence of diabetes
3.4.1.2. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Preference for alternative drug delivery method
3.4.2.2. Lack of skilled professionals
3.5. Pen Needles Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Pen Needles Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Standard Pen Needles
4.1.2. Safety Pen Needles
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Pen Needles Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Standard Pen Needles
4.5.1.1. Standard pen needles market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Safety Pen Needles
4.5.2.1. Safety pen needles market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Pen Needles Market: Needle Length Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. 4mm
5.1.2. 5mm
5.1.3. 6mm
5.1.4. 8mm
5.1.5. 10mm
5.1.6. 12mm
5.2. Needle Length Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Pen Needles Market by Needle Length Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. 4mm
5.5.1.1. 4mm market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. 5mm
5.5.2.1. 5mm market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. 6mm
5.5.3.1. 6mm market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. 8mm
5.5.4.1. 8mm market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. 10mm
5.5.5.1. 10mm market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. 12mm
5.5.6.1. 12mm market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Pen Needles Market: Therapy Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Insulin
6.1.2. Glucagon-like-peptide-1
6.1.3. Growth Harmone
6.2. Therapy Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Pen Needles Market by Therapy Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Insulin
6.5.1.1. Insulin market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Glucagon-like-peptide-1
6.5.2.1. Glucagon-like-peptide-1 market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Growth Harmone
6.5.3.1. Growth harmone market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Pen Needles Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
7.7. Europe
7.7.1. UK
7.7.1.1. Key country dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. UK market estimates and forecasts, 2018 - 2030
7.7.2. Germany
7.7.2.1. Key country dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
7.7.3. France
7.7.3.1. Key country dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. France market estimates and forecasts, 2018 - 2030
7.7.4. Italy
7.7.4.1. Key country dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
7.7.5. Spain
7.7.5.1. Key country dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
7.7.6. Denmark
7.7.6.1. Key country dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
7.7.7. Sweden
7.7.7.1. Key country dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
7.8. Asia Pacific
7.8.1. Japan
7.8.1.1. Key country dynamics
7.8.1.2. Competitive Scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
7.8.2. India
7.8.2.1. Key country dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. India market estimates and forecasts, 2018 - 2030
7.8.3. China
7.8.3.1. Key country dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. China market estimates and forecasts, 2018 - 2030
7.8.4. South Korea
7.8.4.1. Key country dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
7.8.5. Australia
7.8.5.1. Key country dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
7.8.6. Thailand
7.8.6.1. Key country dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
7.9. Latin America
7.9.1. Brazil
7.9.1.1. Key country dynamics
7.9.1.2. Competitive Scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
7.9.2. Mexico
7.9.2.1. Key country dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
7.9.3. Argentina
7.9.3.1. Key country dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
7.10. MEA
7.10.1. South Africa
7.10.1.1. Key country dynamics
7.10.1.2. Competitive Scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement scenario
7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
7.10.2. Saudi Arabia
7.10.2.1. Key country dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
7.10.3. UAE
7.10.3.1. Key country dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
7.10.4. Kuwait
7.10.4.1. Key country dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. Novo Nordisk A/S
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Becton
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Dickinson and Company
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. TERUMO CORPORATION
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Owen Mumford Ltd.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Ypsomed
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. B. Braun Melsungen AG
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. HTL-STREFA
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. UltiMed, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Allison Medical, Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Artsana S.P.a
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiative
List of Tables
Table 1: List of Abbreviation
Table 2: North America Pen needles market, by region, 2018-2030 (USD Million)
Table 3: North America Pen needles market, by product, 2018-2030 (USD Million)
Table 4: North America Pen needles market, by needle length, 2018-2030 (USD Million)
Table 5: North America Pen needles market, by therapy, 2018-2030 (USD Million)
Table 6: U.S. Pen needles market, by product, 2018-2030 (USD Million)
Table 7: U.S. Pen needles market, by needle length, 2018-2030 (USD Million)
Table 8: U.S. Pen needles market, by therapy, 2018-2030 (USD Million)
Table 9: Canada Pen needles market, by product, 2018-2030 (USD Million)
Table 10: Canada Pen needles market, by needle length, 2018-2030 (USD Million)
Table 11: Canada Pen needles market, by therapy, 2018-2030 (USD Million)
Table 12: Europe Pen needles market, by region, 2018-2030 (USD Million)
Table 13: Europe Pen needles market, by product, 2018-2030 (USD Million)
Table 14: Europe Pen needles market, by needle length, 2018-2030 (USD Million)
Table 15: Europe Pen needles market, by therapy, 2018-2030 (USD Million)
Table 16: U.K. Pen needles market, by product, 2018-2030 (USD Million)
Table 17: U.K. Pen needles market, by needle length, 2018-2030 (USD Million)
Table 18: U.K. Pen needles market, by therapy, 2018-2030 (USD Million)
Table 19: Germany Pen needles market, by product, 2018-2030 (USD Million)
Table 20: Germany Pen needles market, by needle length, 2018-2030 (USD Million)
Table 21: Germany Pen needles market, by therapy, 2018-2030 (USD Million)
Table 22: France Pen needles market, by product, 2018-2030 (USD Million)
Table 23: France Pen needles market, by needle length, 2018-2030 (USD Million)
Table 24: France Pen needles market, by therapy, 2018-2030 (USD Million)
Table 25: Italy Pen needles market, by product, 2018-2030 (USD Million)
Table 26: Italy Pen needles market, by needle length, 2018-2030 (USD Million)
Table 27: Italy Pen needles market, by therapy, 2018-2030 (USD Million)
Table 28: Spain Pen needles market, by product, 2018-2030 (USD Million)
Table 29: Spain Pen needles market, by needle length, 2018-2030 (USD Million)
Table 30: Spain Pen needles market, by therapy, 2018-2030 (USD Million)
Table 31: Denmark Pen needles market, by product, 2018-2030 (USD Million)
Table 32: Denmark Pen needles market, by needle length, 2018-2030 (USD Million)
Table 33: Denmark Pen needles market, by therapy, 2018-2030 (USD Million)
Table 34: Sweden Pen needles market, by product, 2018-2030 (USD Million)
Table 35: Sweden Pen needles market, by needle length, 2018-2030 (USD Million)
Table 36: Sweden Pen needles market, by therapy, 2018-2030 (USD Million)
Table 37: Norway Pen needles market, by product, 2018-2030 (USD Million)
Table 38: Norway Pen needles market, by needle length, 2018-2030 (USD Million)
Table 39: Norway Pen needles market, by therapy, 2018-2030 (USD Million)
Table 40: Asia Pacific Pen needles market, by region, 2018-2030 (USD Million)
Table 41: Asia Pacific Pen needles market, by product, 2018-2030 (USD Million)
Table 42: Asia Pacific Pen needles market, by needle length, 2018-2030 (USD Million)
Table 43: Asia Pacific Pen needles market, by therapy, 2018-2030 (USD Million)
Table 44: Japan Pen needles market, by product, 2018-2030 (USD Million)
Table 45: Japan Pen needles market, by needle length, 2018-2030 (USD Million)
Table 46: Japan Pen needles market, by therapy, 2018-2030 (USD Million)
Table 47: China Pen needles market, by product, 2018-2030 (USD Million)
Table 48: China Pen needles market, by needle length, 2018-2030 (USD Million)
Table 49: China Pen needles market, by therapy, 2018-2030 (USD Million)
Table 50: India Pen needles market, by product, 2018-2030 (USD Million)
Table 51: India Pen needles market, by needle length, 2018-2030 (USD Million)
Table 52: India Pen needles market, by therapy, 2018-2030 (USD Million)
Table 53: Australia Pen needles market, by product, 2018-2030 (USD Million)
Table 54: Australia Pen needles market, by needle length, 2018-2030 (USD Million)
Table 55: Australia Pen needles market, by therapy, 2018-2030 (USD Million)
Table 56: Thailand Pen needles market, by product, 2018-2030 (USD Million)
Table 57: Thailand Pen needles market, by needle length, 2018-2030 (USD Million)
Table 58: Thailand Pen needles market, by therapy, 2018-2030 (USD Million)
Table 59: South Korea Pen needles market, by product, 2018-2030 (USD Million)
Table 60: South Korea Pen needles market, by needle length, 2018-2030 (USD Million)
Table 61: South Korea Pen needles market, by therapy, 2018-2030 (USD Million)
Table 62: Latin America Pen needles market, by region, 2018-2030 (USD Million)
Table 63: Latin America Pen needles market, by product, 2018-2030 (USD Million)
Table 64: Latin America Pen needles market, by needle length, 2018-2030 (USD Million)
Table 65: Latin America Pen needles market, by therapy, 2018-2030 (USD Million)
Table 66: Brazil Pen needles market, by product, 2018-2030 (USD Million)
Table 67: Brazil Pen needles market, by needle length, 2018-2030 (USD Million)
Table 68: Brazil Pen needles market, by therapy, 2018-2030 (USD Million)
Table 69: Mexico Pen needles market, by product, 2018-2030 (USD Million)
Table 70: Mexico Pen needles market, by needle length, 2018-2030 (USD Million)
Table 71: Mexico Pen needles market, by therapy, 2018-2030 (USD Million)
Table 72: Argentina Pen needles market, by product, 2018-2030 (USD Million)
Table 73: Argentina Pen needles market, by needle length, 2018-2030 (USD Million)
Table 74: Argentina Pen needles market, by therapy, 2018-2030 (USD Million)
Table 75: Middle East and Africa Pen needles market, by region, 2018-2030 (USD Million)
Table 76: Middle East and Africa Pen needles market, by product, 2018-2030 (USD Million)
Table 77: Middle East and Africa Pen needles market, by needle length, 2018-2030 (USD Million)
Table 78: Middle East and Africa Pen needles market, by therapy, 2018-2030 (USD Million)
Table 79: South Africa Pen needles market, by product, 2018-2030 (USD Million)
Table 80: South Africa Pen needles market, by needle length, 2018-2030 (USD Million)
Table 81: South Africa Pen needles market, by therapy, 2018-2030 (USD Million)
Table 82: Saudi Arabia Pen needles market, by product, 2018-2030 (USD Million)
Table 83: Saudi Arabia Pen needles market, by needle length, 2018-2030 (USD Million)
Table 84: Saudi Arabia Pen needles market, by therapy, 2018-2030 (USD Million)
Table 85: UAE Pen needles market, by product, 2018-2030 (USD Million)
Table 86: UAE Pen needles market, by needle length, 2018-2030 (USD Million)
Table 87: UAE Pen needles market, by therapy, 2018-2030 (USD Million)
Table 88: Kuwait Pen needles market, by product, 2018-2030 (USD Million)
Table 89: Kuwait Pen needles market, by needle length, 2018-2030 (USD Million)
Table 90: Kuwait Pen needles market, by therapy, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Data triangulation techniques
Fig. 3: Primary research pattern
Fig. 4: Primary interviews in North America
Fig. 5: Primary interviews in Europe
Fig. 6: Primary interviews in APAC
Fig. 7: Primary interviews in Latin America
Fig. 8: Primary interviews in MEA
Fig. 9: Market research approaches
Fig. 10: Value-chain-based sizing & forecasting
Fig. 11: QFD modeling for market share assessment
Fig. 12: Market formulation & validation
Fig. 13: Pen needles market: market outlook
Fig. 14: Pen needles market competitive insights
Fig. 15: Parent market outlook
Fig. 16: Related/ancillary market outlook
Fig. 17: Penetration and growth prospect mapping
Fig. 18: Industry value chain analysis
Fig. 19: Pen needles market driver impact
Fig. 20: Pen needles market restraint impact
Fig. 21: Pen needles market strategic initiatives analysis
Fig. 22: Pen needles market: product movement analysis
Fig. 23: Pen needles market: product outlook and key takeaways
Fig. 24: Standard pen needles market estimates and forecast, 2018-2030
Fig. 25: Safety pen needles therapy market estimates and forecast, 2018-2030
Fig. 26: Pen needles market: needle length movement analysis
Fig. 27: Pen needles market: needle length outlook and key takeaways
Fig. 28: 4mm market estimates and forecast, 2018-2030
Fig. 29: 5mm market estimates and forecast, 2018-2030
Fig. 30: 6mm market estimates and forecast, 2018-2030
Fig. 31: 8mm market estimates and forecast, 2018-2030
Fig. 32: 10mm market estimates and forecast, 2018-2030
Fig. 33: 12mm market estimates and forecast, 2018-2030
Fig. 34: Pen needles market: therapy movement analysis
Fig. 35: Pen needles market: therapy outlook and key takeaways
Fig. 36: Insulin market estimates and forecast, 2018-2030
Fig. 37: Glucagon-like-peptide-1 market estimates and forecast, 2018-2030
Fig. 38: Glucagon-like-peptide-1 market estimates and forecast, 2018-2030
Fig. 39: Global Pen needles market: Regional movement analysis
Fig. 40: Global Pen needles market: Regional outlook and key takeaways
Fig. 41: Global market shares and leading players
Fig. 42: North America market share and leading players
Fig. 43: Europe market share and leading players
Fig. 44: Asia Pacific market share and leading players
Fig. 45: Latin America market share and leading players
Fig. 46: Middle East & Africa market share and leading players
Fig. 47: North America: SWOT
Fig. 48: Europe SWOT
Fig. 49: Asia Pacific SWOT
Fig. 50: Latin America SWOT
Fig. 51: MEA SWOT
Fig. 52: North America, by country
Fig. 53: North America
Fig. 54: North America market estimates and forecast, 2018-2030
Fig. 55: U.S.
Fig. 56: U.S. market estimates and forecast, 2018-2030
Fig. 57: Canada
Fig. 58: Canada market estimates and forecast, 2018-2030
Fig. 59: Europe
Fig. 60: Europe. market estimates and forecast, 2018-2030
Fig. 61: U.K.
Fig. 62: U.K. market estimates and forecast, 2018-2030
Fig. 63: Germany
Fig. 64: Germany market estimates and forecast, 2018-2030
Fig. 65: France
Fig. 66: France market estimates and forecast, 2018-2030
Fig. 67: Italy
Fig. 68: Italy market estimates and forecast, 2018-2030
Fig. 69: Spain
Fig. 70: Spain market estimates and forecast, 2018-2030
Fig. 71: Denmark
Fig. 72: Denmark market estimates and forecast, 2018-2030
Fig. 73: Sweden
Fig. 74: Sweden market estimates and forecast, 2018-2030
Fig. 75: Norway
Fig. 76: Norway market estimates and forecast, 2018-2030
Fig. 77: Asia Pacific
Fig. 78: Asia Pacific market estimates and forecast, 2018-2030
Fig. 79: Japan
Fig. 80: Japan market estimates and forecast, 2018-2030
Fig. 81: China
Fig. 82: China market estimates and forecast, 2018-2030
Fig. 83: India
Fig. 84: India market estimates and forecast, 2018-2030
Fig. 85: Australia
Fig. 86: Australia market estimates and forecast, 2018-2030
Fig. 87: Thailand
Fig. 88: Thailand market estimates and forecast, 2018-2030
Fig. 89: South Korea
Fig. 90: South Korea market estimates and forecast, 2018-2030
Fig. 91: Latin America
Fig. 92: Latin America market estimates and forecast, 2018-2030
Fig. 93: Brazil
Fig. 94: Brazil market estimates and forecast, 2018-2030
Fig. 95: Mexico
Fig. 96: Mexico market estimates and forecast, 2018-2030
Fig. 97: Argentina
Fig. 98: Argentina market estimates and forecast, 2018-2030
Fig. 99: Middle East and Africa
Fig. 100: Middle East and Africa market estimates and forecast, 2018-2030
Fig. 101: Saudi Arabia
Fig. 102: Saudi Arabia market estimates and forecast, 2018-2030
Fig. 103: South Africa
Fig. 104: South Africa market estimates and forecast, 2018-2030
Fig. 105: UAE
Fig. 106: UAE market estimates and forecast, 2018-2030
Fig. 107: Kuwait
Fig. 108: Kuwait market estimates and forecast, 2018-2030
Fig. 109: Participant categorization- Pen needles market
Fig. 110: Market share of key market players- Pen needles market

Companies Mentioned

  • Novo Nordisk A/S
  • Becton
  • Dickinson and Company
  • TERUMO CORPORATION
  • Owen Mumford Ltd.
  • Ypsomed
  • B. Braun Melsungen AG
  • HTL-STREFA
  • UltiMed, Inc.
  • Allison Medical, Inc.
  • Artsana S.P.a

Methodology

Loading
LOADING...